Liver MR imaging specialist eyes $75M initial public offering on the Nasdaq
Medical imaging software provider Perspectum is preparing for a $75 million initial public offering, with plans to list on the Nasdaq under the ticker symbol SCAN.
The Oxfordshire, United Kingdom-based firm hopes to raise the funds by offering 4.7 million American depository shares for between $15-$17 apiece. It could command a market value of roughly $637 million, Renaissance Capital said Monday.
Founded in partnership with the University of Oxford in 2012, Perspectum offers an array of image-analysis and artificial intelligence programs. Those include its flagship AI tool LiverMultiScan, cleared by the U.S. Food and Drug Administration in 2015 to aid in the detection of liver disease using MR images. The American Medical Association issued two unique CPT codes tied to the software in January.
Perspectum’s products are currently in use at 350 locations across the globe, and the company booked some $9 million in revenue for the fiscal year that ended March 31, Renaissance reported.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.